Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Viruses
Entry Details
ID
1824
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
P10033 (Created: 1989-07-01 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name
SPIKE_FIPV
Protein Name
Spike glycoprotein
Gene
S
Organism Scientific
Feline coronavirus (strain FIPV WSU-79/1146)
Organism Common
FCoV
Lineage
Viruses
ssRNA positive-strand viruses, no DNA stage
Nidovirales
Coronaviridae
Coronavirus
Coronavirus group 1
Coronavirus group 1a
Protein Length [aa]
1452
Protein Mass [Da]
160470
Features
Type
Description
Status
Start
End
signal peptide
potential
1
19
chain
Spike glycoprotein
potential
20
1452
transmembrane region
potential
1396
1416
topological domain
Extracellular
potential
20
1395
topological domain
Cytoplasmic
potential
1417
1452
glycosylation site
N-linked (GlcNAc...)
potential
29
29
glycosylation site
N-linked (GlcNAc...)
potential
67
67
glycosylation site
N-linked (GlcNAc...)
potential
95
95
glycosylation site
N-linked (GlcNAc...)
potential
155
155
glycosylation site
N-linked (GlcNAc...)
potential
174
174
glycosylation site
N-linked (GlcNAc...)
potential
208
208
glycosylation site
N-linked (GlcNAc...)
potential
234
234
glycosylation site
N-linked (GlcNAc...)
potential
241
241
glycosylation site
N-linked (GlcNAc...)
potential
288
288
glycosylation site
N-linked (GlcNAc...)
potential
337
337
glycosylation site
N-linked (GlcNAc...)
potential
348
348
glycosylation site
N-linked (GlcNAc...)
potential
365
365
glycosylation site
N-linked (GlcNAc...)
potential
408
408
glycosylation site
N-linked (GlcNAc...)
potential
452
452
glycosylation site
N-linked (GlcNAc...)
potential
483
483
glycosylation site
N-linked (GlcNAc...)
potential
519
519
glycosylation site
N-linked (GlcNAc...)
potential
535
535
glycosylation site
N-linked (GlcNAc...)
potential
557
557
glycosylation site
N-linked (GlcNAc...)
potential
565
565
glycosylation site
N-linked (GlcNAc...)
potential
707
707
glycosylation site
N-linked (GlcNAc...)
potential
728
728
glycosylation site
N-linked (GlcNAc...)
potential
783
783
glycosylation site
N-linked (GlcNAc...)
potential
822
822
glycosylation site
N-linked (GlcNAc...)
potential
837
837
glycosylation site
N-linked (GlcNAc...)
potential
843
843
glycosylation site
N-linked (GlcNAc...)
potential
924
924
glycosylation site
N-linked (GlcNAc...)
potential
1077
1077
glycosylation site
N-linked (GlcNAc...)
potential
1203
1203
glycosylation site
N-linked (GlcNAc...)
potential
1297
1297
glycosylation site
N-linked (GlcNAc...)
potential
1314
1314
glycosylation site
N-linked (GlcNAc...)
potential
1327
1327
glycosylation site
N-linked (GlcNAc...)
potential
1339
1339
glycosylation site
N-linked (GlcNAc...)
potential
1344
1344
glycosylation site
N-linked (GlcNAc...)
potential
1361
1361
glycosylation site
N-linked (GlcNAc...)
potential
1374
1374
sequence variant
0
0
sequence variant
0
0
compositionally biased region
Cys-rich
1414
1435
short sequence motif
KxHxx
by similarity
1448
1452
coiled-coil region
potential
1107
1151
coiled-coil region
potential
1341
1383
SP Length
19
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MIVLVTCLLLLCSYHTVLS
Sequence
MIVLVTCLLLLCSYHTVLS
TTNNECIQV
N
VTQLAGNENLIRDFLFSNFKE
EGSVVVGGYYPTEVWY
N
CSRTARTTAFQYFNNIHAFYFVMEAME
N
STGNA
RGKPLLFHVHGEPVSVIISAYRDDVQQRPLLKHGLVCITKNRHINYEQFT
SNQW
N
STCTGADRKIPFSVIPTD
N
GTKIYGLEWNDDFVTAYISGRSYHLN
INTNWFN
N
VTLLYSRSSTATWEYSAAYAYQGVS
N
FTYYKL
N
NTNGLKTYE
LCEDYEHCTGYATNVFAPTSGGYIPDGFSFNNWFLLT
N
SSTFVSGRFVTN
QPLLINCLWPVPSFGVAAQEFCFEGAQFSQCNGVSL
N
NTVDVIRFNL
N
FT
ADVQSGMGATVFSL
N
TTGGVILEISCYSDTVSESSSYSYGEIPFGITDGP
RYCYVLY
N
GTALKYLGTLPPSVKEIAISKWGHFYINGYNFFSTFPIGCIS
F
N
LTTGVSGAFWTIAYTSYTEALVQVENTAIK
N
VTYCNSHINNIKCSQLT
ANLNNGFYPVASSEVGFV
N
KSVVLLPSFFTYTAV
N
ITIDLGMKLSGYGQP
IASTLS
N
ITLPMQD
N
NTDVYCIRSNQFSVYVHSTCKSSLWDNIFNQDCTD
VLEATAVIKTGTCPFSFDKLNNYLTFNKFCLSLSPVGANCKFDVAARTRT
NEQVVRSLYVIYEEGDNIVGVPSDNSGLHDLSVLHLDSCTDYNIYGRTGV
GIIRRT
N
STLLSGLYYTSLSGDLLGFK
N
VSDGVIYSVTPCDVSAQAAVID
GAIVGAMTSINSELLGLTHWTTTPNFYYYSIY
N
YTSERTRGTAIDSNDVD
CEPVITYSNIGVCKNGALVFI
N
VTHSDGDVQPISTG
N
VTIPT
N
FTISVQV
EYMQVYTTPVSIDCARYVCNGNPRCNKLLTQYVSACQTIEQALAMGARLE
NMEVDSMLFVSENALKLASVEAF
N
STENLDPIYKEWPSIGGSWLGGLKDI
LPSHNSKRKYGSAIEDLLFDKVVTSGLGTVDEDYKRCTGGYDIADLVCAQ
YYNGIMVLPGVANADKMTMYTASLAGGITLGALGGGAVAIPFAVAVQARL
NYVALQTDVLNKNQQILANAFNQAIG
N
ITQAFGKVNDAIHQTSQGLATVA
KALAKV
QDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAQ
V
DRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGF
CG
N
GTHLFSLANAAPNGMIFFHTVLLPTAYETVTAWSGICASDGDRTFGL
VVKDVQLTLFRNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFV
N
ATV
IDLPSIIPDYIDI
N
QTVQDILENYRP
N
WTVPEFTLDIF
N
A
TYLNLTGEID
DLEFRSEKLHNTTVELAILIDNINNTLVNLEWL
NRIETYVKWPWY
VWLLI
GLVVVFCIPLLLF
CCFSTGCCGCIGCLGSCCHSIC
SRRQFENYEPIE
KVH
VH
Original
MIVLVTCLLLLCSYHTVLSTTNNECIQVNVTQLAGNENLIRDFLFSNFKE
EGSVVVGGYYPTEVWYNCSRTARTTAFQYFNNIHAFYFVMEAMENSTGNA
RGKPLLFHVHGEPVSVIISAYRDDVQQRPLLKHGLVCITKNRHINYEQFT
SNQWNSTCTGADRKIPFSVIPTDNGTKIYGLEWNDDFVTAYISGRSYHLN
INTNWFNNVTLLYSRSSTATWEYSAAYAYQGVSNFTYYKLNNTNGLKTYE
LCEDYEHCTGYATNVFAPTSGGYIPDGFSFNNWFLLTNSSTFVSGRFVTN
QPLLINCLWPVPSFGVAAQEFCFEGAQFSQCNGVSLNNTVDVIRFNLNFT
ADVQSGMGATVFSLNTTGGVILEISCYSDTVSESSSYSYGEIPFGITDGP
RYCYVLYNGTALKYLGTLPPSVKEIAISKWGHFYINGYNFFSTFPIGCIS
FNLTTGVSGAFWTIAYTSYTEALVQVENTAIKNVTYCNSHINNIKCSQLT
ANLNNGFYPVASSEVGFVNKSVVLLPSFFTYTAVNITIDLGMKLSGYGQP
IASTLSNITLPMQDNNTDVYCIRSNQFSVYVHSTCKSSLWDNIFNQDCTD
VLEATAVIKTGTCPFSFDKLNNYLTFNKFCLSLSPVGANCKFDVAARTRT
NEQVVRSLYVIYEEGDNIVGVPSDNSGLHDLSVLHLDSCTDYNIYGRTGV
GIIRRTNSTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCDVSAQAAVID
GAIVGAMTSINSELLGLTHWTTTPNFYYYSIYNYTSERTRGTAIDSNDVD
CEPVITYSNIGVCKNGALVFINVTHSDGDVQPISTGNVTIPTNFTISVQV
EYMQVYTTPVSIDCARYVCNGNPRCNKLLTQYVSACQTIEQALAMGARLE
NMEVDSMLFVSENALKLASVEAFNSTENLDPIYKEWPSIGGSWLGGLKDI
LPSHNSKRKYGSAIEDLLFDKVVTSGLGTVDEDYKRCTGGYDIADLVCAQ
YYNGIMVLPGVANADKMTMYTASLAGGITLGALGGGAVAIPFAVAVQARL
NYVALQTDVLNKNQQILANAFNQAIGNITQAFGKVNDAIHQTSQGLATVA
KALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAQ
VDRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGF
CGNGTHLFSLANAAPNGMIFFHTVLLPTAYETVTAWSGICASDGDRTFGL
VVKDVQLTLFRNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNATV
IDLPSIIPDYIDINQTVQDILENYRPNWTVPEFTLDIFNATYLNLTGEID
DLEFRSEKLHNTTVELAILIDNINNTLVNLEWLNRIETYVKWPWYVWLLI
GLVVVFCIPLLLFCCFSTGCCGCIGCLGSCCHSICSRRQFENYEPIEKVH
VH
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11